Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Doximity, Inc. (DOCS) Guidance & Earnings Results

On 2026-08-06 Doximity, Inc. raised guidance: "FY revenue guidance raised to $671-681M (prior not given but implied…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DOCSDoximity, Inc.Follow DOCS — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
6.0B
P/E TTM
39.3
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Aug 26RaisedFY revenue guidance raised to $671-681M (prior not given but implied beat) · full year
13 May 26ReaffirmedQ1 FY27 revenue $151M-$152M; FY27 revenue $664M-$676M; FY27 adjusted EBITDA $323M-$335M · full year
5 Feb 26ReaffirmedQ4 FY26 revenue $143-144M; Adjusted EBITDA $63.5-64.5M; FY26 revenue $642.5-643.5M; Adjusted EBITDA $355.5-356.5M · full year
6 Nov 25RaisedQ3 revenue $180-181M; FY revenue $640-646M
7 Aug 25RaisedFY2026 revenue raised to $628-636M; FY2026 adjusted EBITDA raised to $341-349M; Q2 FY2026 revenue $157-158M; Q2 FY2026 adjusted EBITDA $87-88M · full year

Doximity, Inc. — questions

What guidance did Doximity, Inc. give?
On 2026-08-06: "FY revenue guidance raised to $671-681M (prior not given but implied beat)"
When does Doximity, Inc. report earnings?
Doximity, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from Doximity, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.